Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Neuroscience (ANRO) Cash from Financing Activities (2023 - 2026)

Alto Neuroscience has reported Cash from Financing Activities over the past 4 years, most recently at $114.9 million for Q1 2026.

  • Quarterly results put Cash from Financing Activities at $114.9 million for Q1 2026, up 1159.35% from a year ago — trailing twelve months through Mar 2026 was $165.9 million (up 1517.04% YoY), and the annual figure for FY2025 was $60.1 million, down 55.72%.
  • Cash from Financing Activities reached $114.9 million in Q1 2026 per ANRO's latest filing, up from $50.2 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $134.6 million in Q1 2024 and bottomed at -$234000.0 in Q2 2024.
  • Median Cash from Financing Activities over the past 4 years was $1.3 million (2024), compared with a mean of $29.1 million.
  • The largest annual shift saw Cash from Financing Activities crashed 358.82% in 2024 before it skyrocketed 102318.37% in 2025.
  • Over 4 years, Cash from Financing Activities stood at $43.1 million in 2023, then tumbled by 99.89% to $49000.0 in 2024, then surged by 102318.37% to $50.2 million in 2025, then surged by 129.03% to $114.9 million in 2026.
  • Business Quant data shows Cash from Financing Activities for ANRO at $114.9 million in Q1 2026, $50.2 million in Q4 2025, and $153000.0 in Q3 2025.